Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > We should trust someone who took the company from 1.50 to

<< Previous

Bullboard Posts

Next >>

Comment by Kingofstockston Oct 04, 2021 8:51am

270 Views

Post# 33959991

RE:RE:We should trust someone who took the company from 1.50 to

The din he is referring 2 has nothing to do with the FDA trials you mention, the din is for redevu which should be granted any time now as it was already approved by HC previously and is approved by the fda, so if your going to BS at least make it make sense... the reborn trial will get interm results soon as it's attached to plenitude which primary should of been done Sept 2021 ..... it's coming boyz and girls buckle up could get interesting

<< Previous

Bullboard Posts

Next >>

StockTalk | Cannabis Report: New CEO, new dispensaries, new strains